Autophagic degradation of CDK4 is responsible for G0/G1 cell cycle arrest in NVP-BEZ235-treated neuroblastoma

Zhen Liu1,2, Xiao-Yang Wang3, Han-Wei Wang4

  • 1Department of Clinical Laboratory, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.

PubMed
Abstract

Insights

Targeting CDK4 degradation via autophagy is a novel therapeutic strategy for neuroblastoma (NB). This study reveals that autophagy, mediated by p62 and CTSB, degrades CDK4, inducing cell cycle arrest in NB cells.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Cyclin-dependent kinase 4 (CDK4) is highly expressed in advanced neuroblastoma (NB), correlating with poor prognosis and reduced survival.
  • Targeting CDK4 degradation offers a promising therapeutic avenue beyond traditional CDK4 inhibitors.
  • The role of autophagic degradation of CDK4 and its anti-proliferative effects in NB cells remained uncharacterized.

Purpose of the Study:

  • To investigate the role of autophagy in CDK4 degradation within neuroblastoma cells.
  • To elucidate the mechanism of CDK4 autophagic degradation and its impact on cell cycle progression.
  • To explore the therapeutic potential of targeting CDK4 degradation in neuroblastoma.

Main Methods:

  • Investigated CDK4 degradation using autophagy inhibition and gene blockade in NVP-BEZ235 treated NB cells.
  • Utilized p62 and CTSB (cathepsin B) to demonstrate the mechanism of CDK4 binding and lysosomal degradation.
  • Validated findings in a neuroblastoma xenograft mouse model.

Main Results:

  • Autophagic degradation of CDK4 was identified as a critical mechanism for NVP-BEZ235-induced G0/G1 cell cycle arrest.
  • Overexpression of CDK4 and inhibition of autophagy confirmed the dependency of cell cycle arrest on CDK4 degradation.
  • p62 was found to bind CDK4, facilitating its lysosomal degradation in a CTSB-dependent manner in NB cells and xenografts.

Conclusions:

  • Autophagic degradation of CDK4 is a key mediator of G0/G1 cell cycle arrest in neuroblastoma cells treated with NVP-BEZ235.
  • This pathway represents a novel therapeutic target for neuroblastoma treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
2.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
157
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.0K